Genetics

This blog post examines a landmark Mendelian randomization study investigating whether low vitamin D status contributes directly to the development of multiple sclerosis rather than merely accompanying the disease. By using genetic variants associated with circulating 25-hydroxyvitamin D as proxies for lifelong vitamin D exposure, the researchers found that genetically reduced vitamin D levels were associated with substantially higher odds of multiple sclerosis. The post explains the study design, principal findings, biological plausibility, methodological strengths, and important limitations, while emphasizing that the results support further prevention trials but do not by themselves prove that vitamin D supplementation can prevent or treat multiple sclerosis.